New open source initiative integrates and builds a data platform and tools to accelerate grid planning and energy infrastructure deployments worldwide 

PRAGUE, Oct. 7, 2026 /PRNewswire/ — Open Source Summit Europe – The Linux Foundation, the nonprofit organization enabling mass innovation through open source, today announced the launch of OpenGrid, a new initiative building open source infrastructure to modernize power grid planning worldwide. Hosted by the Linux Foundation, OpenGrid creates a neutral, interoperable foundation that allows planners to work across the commercial and open source software they already use, helping reduce the time, cost and technical barriers involved in planning the infrastructure needed to meet rapidly growing electricity demand. 

Grid planning has become a critical bottleneck as electricity demand grows, new data center and industrial loads come online and more generation and storage seek connection. More than 2,500
 gigawatts of generation, storage and large-load projects are currently pending in grid connection queues worldwide, while annual grid investment needs to roughly double to more than $600 billion by 2030. Meeting long-term energy needs will require adding or replacing 80 million kilometers of power lines by 2040, yet planning remains constrained by fragmented data, incompatible software and modeling capabilities that are inaccessible to many institutions and countries. 

“Open source has repeatedly shown that shared architecture and interoperability accelerate innovation across entire industries,” said Jim Zemlin, CEO of the Linux Foundation. “OpenGrid will bring the proven model of open collaboration to grid planning for faster and more reliable deployment. The Linux Foundation’s neutral governance will ensure durability, longevity and usability of the technologies that support essential public-interest infrastructure.” 

OpenGrid is not developing a single replacement for existing grid planning software. Instead, it provides a shared data and interoperability layer that allows existing commercial and open source tools to work together. Its foundational efforts will include open standards and schemas, programmatic APIs and a centralized Data Hub for validated, model-ready datasets. Its first lighthouse application, the OpenGrid Translator, is in development for release in 2027 and will enable data and models to move between widely used commercial platforms and open source tools. 

Access to modern planning capabilities is particularly uneven in fast-growing markets. At the same time, emerging economies are expected to account for nearly 80% of global electricity demand growth through 2030. OpenGrid aims to give planning teams everywhere access to high-quality modeling capabilities, while enabling regulators, advocates and other stakeholders to inspect the models and data informing major infrastructure decisions. 

“Reliable electricity supports healthier lives, stronger communities and economic opportunity, but delivering it requires credible plans. Today, too many plans rely on data others cannot verify and tools much of the world cannot afford,” said Alice Yake, vice president of BE-GRIDS and chair of the OpenGrid Management Committee. “OpenGrid changes that: open data, open standards and access to planning tools that any utility, regulator or country can inspect and use.” 

Over time, the OpenGrid ecosystem plans to expand to include open solvers, no-code graphical interfaces, standardized planning workflows and integrations that use AI to support data preparation. By providing transparent, repeatable and accessible planning infrastructure, OpenGrid aims to help planners, infrastructure owners, regulators and communities work from a common technical foundation and make infrastructure decisions with greater confidence faster. 

OpenGrid launches with support from Breakthrough Energy GRIDS, Global Grid Catalyst, Connected Grid Initiative and Google.org, with technical delivery partners including Open Energy Transition, Tapestry, TransitionZero and QXT Energy. 

Organizations, researchers, regulators and community members interested in contributing to OpenGrid or learning more are encouraged to visit https://www.opengrid.org. 

Supporting Quotes 

“Electricity systems are going through some pretty radical changes, with many new variable producers, storage and consumers connecting to the grid. OpenGrid supports the infrastructure we need to get quick consensus on how the energy transition should proceed, and to foster the innovation we need to drive it forward faster.” 

– Tom Brown, Professor of Digital Transformation in Energy Systems, TU Berlin and Managing Director, PyPSA Labs 

“Planners shouldn’t have to choose between the tools they already use and the open ones now emerging. Building enterprise-grade, open modeling software with Scenario Builder showed us how much time is lost moving data and models between formats. OpenGrid’s shared standards and translators tackle that directly, and we’re glad to help build them, so that planners anywhere can pick up a model, inspect it, use it and make decisions that cut the time it takes to build clean energy at scale.” 

– Matt Gray, Co-Founder and CEO, TransitionZero 

“Accelerating scientific progress requires turning foundational research and open data into real-world solutions. Power grids are among humanity’s most complex engineering systems, yet modeling them is too often limited by fragmented tools and closed data. OpenGrid will provide the shared digital foundation needed to make faster, more evidence-based decisions and ultimately strengthen our global grid infrastructure.” 

– Joseph Hassine, Scaled Impact Lead, Google.org
 

“OpenGrid is the catalyst that the power and energy industry needs to drive new software innovations that ultimately will produce better and faster decision making for the power grid. We keep hearing that these times are unprecedented and yet we have seen very few changes in the power software space. OpenGrid’s ambitions to demonstrate that open source can be the driver for much needed innovation is something that QXT Energy is enthusiastic to support.” 

– José Daniel Lara, Co-Founder and CTO, QXT Energy 

“The accelerating complexity of the modern power system demands better integration of economic and reliability planning tools, as well as coordinated planning across the transmission and distribution networks. OpenGrid is tackling this ambitious challenge by enabling these diverse tools, whether open source or commercial, to work together and by providing validated datasets. This has the potential to revolutionize grid planning across the globe.” 

– Debbie Lew, Executive Director, Energy Systems Integration Group (ESIG) 

“At OpenET, we make water use data open and accessible, so I’ve seen firsthand how a shared baseline builds trust among diverse stakeholders. That experience convinces me that open data infrastructure is essential to sound resource management. By giving planners, regulators and communities a common ground truth they can all inspect and understand, OpenGrid will help them make the decisions the energy transition demands.” 

– Luis Villa, Board Chair, OpenET, Inc. 

“Transparent and neutral governance ensures that all interested users have access to the tools in this initiative. It allows users to decide what is best for their purposes, and it keeps the door open for new tool development to foster innovation and avoid lock-in. Transparency in decision-making creates community buy-in. When parties come together on shared infrastructure, working toward common objectives and the methods and results can be vetted by many parties, this builds the trust and sense of fairness and legitimacy that will be necessary for OpenGrid to be successful.” 

– Karin Wadsack, Executive Director, Global Power System Transformation Consortium 

About the Linux FoundationThe Linux Foundation is the world’s leading home for collaboration on open source software, hardware, standards, and data. Linux Foundation projects, including Linux, Kubernetes, Model Context Protocol (MCP), OpenChain, OpenSearch, OpenSSF, OpenStack, PyTorch, Ray, RISC-V, SPDX and Zephyr, provide the foundation for global infrastructure. The Linux Foundation is focused on leveraging best practices and addressing the needs of contributors, users, and solution providers to create sustainable models for open collaboration. For more information, please visit us at linuxfoundation.org. 

The Linux Foundation has registered trademarks and uses trademarks. For a list of trademarks of the Linux Foundation, please see its trademark usage page: www.linuxfoundation.org/trademark-usage. Linux is a registered trademark of Linus Torvalds. 

Media ContactThe Linux Foundationpr@linuxfoundation.org  

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/linux-foundation-launches-opengrid-to-build-open-shared-infrastructure-for-the-worlds-electric-grid-302900460.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

xFusion will contribute its infrastructure expertise to open source communities across the Linux Foundation     

PRAGUE, Oct. 7, 2026 /PRNewswire/ — Open Source Summit Europe — xFusion, a leading global provider of AI computing infrastructure, today announced that it has joined the Linux Foundation, the world’s leading organization for open source collaboration, as a Silver member. As part of its engagement, xFusion is also participating in the SODA Foundation, the Linux Foundation community focused on data and AI infrastructure. Through its membership, xFusion plans to engage with open source communities working across cloud and AI infrastructure and contribute technical expertise informed by its work in computing systems, infrastructure efficiency and operations. 

As both an AI infrastructure provider and an active open source contributor, xFusion also plans to deepen its engagement with upstream open source communities supporting cloud and AI infrastructure. This work will inform the continued development and interoperability of FusionOS while creating opportunities for xFusion engineers to contribute to relevant community-led projects. As enterprises deploy increasingly heterogeneous AI environments — spanning multiple accelerators, foundation models, inference engines and software platforms — the industry is still developing common, open methodologies for measuring, managing and optimizing AI infrastructure. Through the Linux Foundation and its communities, xFusion will collaborate with technology companies, researchers and enterprise users worldwide to help develop open benchmarks, reference architectures and operational best practices for enterprise AI infrastructure.               

xFusion’s open source participation is anchored by the xFusion Singapore Open Lab, the company’s global open innovation hub. Located in Singapore, one of the world’s leading technology and business hubs connecting East and West, the Open Lab provides a neutral platform where AI hardware, foundation models, software platforms, researchers, enterprises and open source communities from different innovation ecosystems can collaborate, evaluate and benchmark technologies using open methodologies.     

 “AI infrastructure can only reach its full potential through open collaboration. The industry needs vendor-neutral methodologies to measure, manage and optimize increasingly diverse AI environments,” said Fan RuiQi, CTO & President of Central Research Department, xFusion. “Joining the Linux Foundation allows us to work with the global community to build those foundations — and through our Singapore Open Lab, to provide a neutral platform where innovations from across the world’s technology ecosystems advance together.” 

“xFusion builds infrastructure that AI runs on, and it’s putting its benchmarking and observability work into open projects where others can build on it,” said Michael Dolan, SVP of Legal and Strategic Programs, Linux Foundation. “We welcome them to the Linux Foundation and building on prior collaborations like SODA Foundation.” 

Building on its AI inference benchmarking research, xFusion is developing an open framework for AI Infrastructure Efficiency & Intelligence — bringing standardized observability, benchmarking, efficiency measurement and operational intelligence to heterogeneous AI environments. Aitra, an open reference platform incubating under the SODA Foundation, is among the first implementations of this vision. 

Through its membership, xFusion intends to: 

About xFusion 

XFUSION INTERNATIONAL PTE. LTD. (xFusion) is a leading global provider of computing infrastructure, smart energy solutions, and related services. Driven by the vision “Let Computing Serve You Better,” xFusion focuses on creating value for its customers and partners, accelerating digital transformation across a wide range of industries. Headquartered in Singapore, xFusion has a substantial global presence, including 8 research centers, 7 regional offices, and 6 Global Technical Assistance Centers (GTACs). xFusion’s commitment to providing innovative computing and energy solutions has enabled it to serve over 10,000 customers in more than 110 countries and regions, including the telecom, finance, internet, transportation, and energy sectors. 

The xFusion Global Supply Center in Penang, Malaysia, is designed for an annual production capacity of 200,000 servers, encompassing xFusion’s complete product portfolio. The center’s streamlined logistics and delivery capabilities ensure timely and efficient service to customers worldwide. This strategic location allows xFusion to optimize its operations, guaranteeing the highest quality standards and efficient delivery of its products and services. 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/xfusion-joins-the-linux-foundation-to-support-open-source-innovation-302899512.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

European organizations report strong returns from open source as AI adoption, regulation and technology sovereignty reshape software strategy 

PRAGUE, Oct. 7, 2026 /PRNewswire/ — Open Source Summit Europe – The Linux Foundation, the non-profit organisation enabling mass innovation through open source, today released the 2026 State of Open Source in Europe report in collaboration with LF Europe, LF Research and NeoNephos. The fifth annual report revealed that digital sovereignty is now firmly embedded in European technology strategy. Ninety-four percent of organizations say digital sovereignty is important, including 61% that consider it very important, while organizations with advanced open source governance report an average return of more than 4x their investment, compared with 3.6x among organizations without formal governance. 

The findings point to a critical next step: European organizations seeking greater control over their technology supply chains must move beyond simply consuming open source software and participate in the openly governed ecosystems that develop and sustain it. European developers account for nearly 40% of contributions to foundational infrastructure projects including Kubernetes and OpenStack. At the same time, 94% of organizations are using or piloting generative AI coding tools, 48% maintain private forks of open source projects and 63% have increased investment in open source dependency management in response to regulatory pressure.  

“Europe has clearly heard the message on digital sovereignty. The next step is participation,” said Thierry Carrez, general manager, Linux Foundation Europe. “Open source gives organizations a way to reduce dependence on any single vendor or country, but consuming open source alone doesn’t give you effective control over the technology. By contributing upstream and participating in open governance, European organizations can achieve greater autonomy, efficiently leveraging the global open source technology commons.” 

Additional findings from the 2026 report include: 

“Five years of research confirms how critical open source is to Europe’s tech landscape,” said Hilary Carter, senior vice president of research, Linux Foundation. “With the 2026 Tech Sovereignty Package expected to spur €2 billion in digital infrastructure investment, realizing that value requires more than adopting software – it demands strong governance and active community contribution.” 

The full 2026 State of Open Source in Europe report is now available. To learn more about membership to the Linux Foundation Europe, visit https://linuxfoundation.eu/en/join. For information about how to contribute to open source projects, review the Linux Foundation Open Source Guide book. 

About the Linux Foundation 

The Linux Foundation is the world’s leading home for collaboration on open source software, hardware, standards, and data. Linux Foundation projects, including Linux, Kubernetes, Model Context Protocol (MCP), OpenChain, OpenSearch, OpenSSF, OpenStack, PyTorch, Ray, RISC-V, SPDX and Zephyr, provide the foundation for global infrastructure. The Linux Foundation is focused on leveraging best practices and addressing the needs of contributors, users, and solution providers to create sustainable models for open collaboration. For more information, please visit us at linuxfoundation.org. 

The Linux Foundation has registered trademarks and uses trademarks. For a list of trademarks of the Linux Foundation, please see its trademark usage page: www.linuxfoundation.org/trademark-usage. Linux is a registered trademark of Linus Torvalds. 

Media Contact 

The Linux Foundationpr@linuxfoundation.org  

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/linux-foundation-europe-report-finds-digital-sovereignty-drives-european-tech-strategy-but-governance-and-ai-strain-present-major-hurdles-302900611.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

ORTEC advances AI-powered planning for more adaptive, resilient logistics operations. 

ZOETERMEER, Netherlands, Oct. 7, 2026 /PRNewswire/ — ORTEC, a global leader in planning and decision-support software, today announced it has been mentioned as a Representative Vendor in the 2026 Gartner®  Market Guide for Vehicle Routing and Scheduling (VRS). We hold the view that this recognition comes at a time when logistics organizations are facing growing operational complexity, increasing sustainability requirements and rising customer expectations, while simultaneously exploring how AI can improve planning, decision-making and execution. 

For ORTEC, inclusion in the Market Guide underscores the company’s continued investment in enabling organizations to move beyond traditional route optimization toward more intelligent, and adaptive logistics operations. As businesses seek solutions that can respond dynamically to disruptions, capacity constraints and changing delivery environments, ORTEC believes its combination of advanced optimization, logistics expertise and AI-powered decision support is uniquely positioned to help customers create lasting business value.  

“We are proud to be recognized as a Representative Vendor in the 2026 Gartner Market Guide for Vehicle Routing and Scheduling,” said Georgios Sarigiannidis, CEO of ORTEC. “We feel this reflects both the trust our customers place in us and the technology and expertise we have built over decades. Logistics operations are becoming increasingly complex. Organizations do not need more dashboards, alerts, or decisions. They need trusted systems that remove operational noise, automate what can be automated, and help people focus on what truly matters. By combining optimization, AI, and deep logistics expertise, ORTEC helps organizations build more resilient, efficient, and adaptable operations. We believe Gartner’s recognition reinforces the direction we have chosen and the value we continue to deliver to customers every day”. 

Gartner defines a vehicle routing and scheduling (VRS) solution as “an application that creates vehicle routes and schedules, considering multiple constraints and service requirements while minimizing transportation fleet costs and mileage.” Gartner’s research notes that “The interest in VRS applications continues to grow, fueled by continued challenges resulting from supply chain disruptions, government regulations on emissions and expansion of various delivery models.” 

Among its key findings, Gartner reports that the influence of AI is being reflected in the VRS market: “AI is having a significant impact on VRS vendor roadmaps, transforming it from a feature enhancement into a core strategic mandate for future development,” with most vendors already exploring AI agents and generative AI to support roles including dispatchers, planners, drivers, and customer support. 

For our customers, partners, and prospective clients, we believe ORTEC’s inclusion in the Market Guide reflects the company’s expertise, market relevance, and commitment to AI driven innovation. In a rapidly evolving logistics landscape, organizations require partners they can rely on to navigate complexity, drive performance and embrace emerging technologies with confidence.   

The 2026 Gartner Market Guide for Vehicle Routing and Scheduling is available on Gartner’s website to Gartner subscribers.  

Gartner Disclaimer   

Gartner, Market Guide for Vehicle Routing and Scheduling, Nathan Lease, Zee Zakaria,, 17 July 2026 

GARTNER is a trademark of Gartner, Inc. and/or its affiliates. Gartner does not endorse any company, vendor, product or service depicted in its publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner publications consist of the opinions of Gartner’s business and technology insights organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this publication, including any warranties of merchantability or fitness for a particular purpose.  

About ORTEC  

ORTEC is a global provider of AI-powered supply chain planning, logistics optimization and workforce management software. Since 1981, ORTEC has helped organizations across industries transform operational complexity into better decisions, more efficient use of resources and stronger business performance. With customers around the world and an international presence spanning Europe, North America, Latin America, Asia-Pacific and beyond, ORTEC combines deep optimization expertise with practical AI to help organizations adapt to change and make work flow. 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/ortec-mentioned-as-a-representative-vendor-in-2026-gartner-market-guide-for-vehicle-routing-and-scheduling-302897018.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

Per maggiori informazioni sulla Giornata internazionale della dislessia è possibile consultare il portale www.disfam.org/8oct.

FIRENZE – La Fisac Cgil Toscana ha partecipato alla riunione dell’Osservatorio sulla desertificazione bancaria che si è aperta con la presentazione del rapporto Irpet La rarefazione dei servizi bancari in Toscana.

Su 273 comuni toscani, 31 non hanno più alcuno sportello bancario: vi vivono più di 60 mila persone. Altri 58 comuni ne hanno uno soltanto, per una popolazione di oltre 160 mila abitanti. In tutto sono 89 comuni, quasi uno su tre, in cui 220 mila cittadine e cittadini non hanno una banca sotto casa oppure dipendono da un’unica filiale, che basta chiudere per trasformare il comune in un deserto bancario.
“Dietro questi numeri c’è una questione di inclusione finanziaria e quindi di possibilità di iniziativa economica e partecipazione alla vita sociale, politica e organizzativa del territorio – dichiara Sabrina Marricchi, segretaria generale della Fisac Cgil Toscana – Dove resta un solo sportello non esiste più alcuna possibilità di scelta se non spostandosi di chilometri. Una situazione che pesa soprattutto sulle aree interne e montane e su chi ha meno dimestichezza con i servizi digitali».

La Fisac Cgil Toscana richiama inoltre l’attenzione sul risiko bancario in corso, che coinvolge in pieno la nostra regione. “Qualunque sia l’esito della partita, il risultato sarà un’ulteriore concentrazione tra grandi gruppi – prosegue Sabrina Marricchi – L’esperienza di questi anni ci dice che ogni accorpamento si traduce nel rischio di chiusure di filiali, con ricadute sui territori e sull’occupazione. La Toscana non può permettersi un’altra stagione di tagli”.

Per questo la Fisac Cgil Toscana ritiene che l’Osservatorio sulla desertificazione bancaria debba diventare cabina di regia permanente (utilizzando gli indici di esposizione alla rarefazione finanziaria proposti da Irpet per attuare impegni concreti sul mantenimento della presenza fisica nei territori, a partire dai comuni oggi serviti da un solo sportello), debba promuovere strumenti innovativi e auspicare un confronto preventivo con le parti sociali su ogni piano di riorganizzazione della rete.

REDAZIONE

SEOUL, South Korea and MILAN, Oct. 7, 2026 /PRNewswire/ — LG CNS, a leading AI Transformation company in Korea, is expanding its manufacturing AX business with a showcase of pharma-specific smart factory technologies at CPHI Milan 2026, the world’s largest pharmaceutical and biotech exhibition. 

The Convention on Pharmaceutical Ingredients (CPHI) is a global pharma and biotech trade show held at various global venues throughout the year, including the United States, Europe, Asia, and the Middle East. The Milan show is CPHI’s flagship event, drawing around 60,000 visitors and roughly 3,000 companies from more than 160 countries. It is widely regarded as the premier stage on which the latest technologies and trends of the global pharma and biotech industry converge. LG CNS is the only Korean company participating in the newly created “AI & Tech” zone this year. 

The theme of LG CNS’s booth is Autonomous Factory in Pharma and is designed around the introduction of three smart factory solutions connecting factory design, production operations, and quality management. Pharma and biotech companies building or expanding production facilities can adopt these solutions across the entire process, from factory construction through ongoing operations. 

For the factory design stage, LG CNS presents Factova Worldworks, a digital twin-based virtual validation simulator that recreates the actual factory in a virtual space. It models the factory layout in 3D to review the optimal placement of pharmaceutical manufacturing equipment, the routes that workers will take within the planned factory, and the path along which raw materials are to be transferred. Pharmaceutical factories separate zones such as cleanrooms and production areas to prevent raw material contamination. Worker access permissions also differ by zone, so planning their routes carefully in advance is more essential than in general manufacturing factories. 

Factova Control is a data standardization and equipment control solution for the production operations stage. It automatically converts process data such as raw material ID numbers and formulations into a unified format, unit, and notation so that every manufacturing step works from consistent data. This lets customers respond immediately when adding new equipment or changing process workflows. The solution also detects equipment anomalies and predicts failures, using AI to analyze electrical current, temperature, and vibration data in real time to flag early warning signs. 

The quality management solution analyzes data such as production volume, raw material temperature changes, and equipment operation history to check for product quality issues. It also supports everything from root-cause investigations to follow-up actions when problems are identified. Notably, when it detects an anomaly midway through a process, it immediately calculates alternatives to resolve the issue and then applies them to the next production step, proactively preventing defective products. 

An AI agent trained on quality data also drafts the Annual Product Quality Review (APQR). Pharma and biotech companies conduct annual quality reviews to comply with each country’s Good Manufacturing Practice (GMP) regulations and document the results in the APQR. Previously, staff collected, analyzed, and verified the required data by hand, a process that could take months. LG CNS has automated the entire process with AI, cutting the time required by more than 90%. 

“The manufacturing AX solutions we are showcasing at this exhibition are tailored to pharma so we can support our pharma and biotech customers with intelligent automation across the entire process, from factory design to quality management,” said Eddie Jang, Head of the Chemical/Battery Division at LG CNS. “As a turnkey provider covering every area of manufacturing, we will continue to use our advanced solutions to address the challenges of developing pharmaceutical manufacturing sites, which demand high precision and strict quality standards, and help customers produce medicines in a more automated and efficient way.” 

About LG CNS 

LG CNS is a leading Korean AX (AI Transformation) company that continues to pioneer various emerging technologies, including AI, robotics, cloud computing, data center, and smart engineering, encompassing smart factories and smart logistics, as well as digital marketing. The company also leads the market through innovative system integration (SI) and system management (SM) capabilities across finance, manufacturing, the public sector, and various other industries. For more information, please visit https://www.lgcns.com. 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/lg-cns-showcases-pharma-specific-manufacturing-ax-at-worlds-largest-pharma-biotech-show-302900801.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

DeepSights MCP, now generally available, connects an expert market intelligence AI to Microsoft Copilot, ChatGPT, Claude and custom agents, so everyday AI work draws on accurate, cited market evidence 

BERLIN, Oct. 7, 2026 /PRNewswire/ — Market Logic Software, the company behind  DeepSights. the leading AI market intelligence platform, today announced the general availability of DeepSights MCP. The Model Context Protocol (MCP) connection makes DeepSights the expert source that enterprise AI assistants and agents consult whenever a question depends on knowledge of the market. It extends the reach of each customer’s curated market knowledge from the insights team to every employee and every AI workflow in the business. 

Large organizations invest tens of millions every year in consumer and market research. The return on that investment depends on how widely, and how often, the resulting insights shape business decisions. Connecting trusted market intelligence to the rapid spread of enterprise AI assistants, from Microsoft Copilot to ChatGPT and Claude, creates a golden opportunity to extend insights impact to a new level. 

Once the DeepSights MCP is in place, AI assistants call on DeepSights as a matter of course to answer questions about customers, categories and competitors. Similarly, automated, multi-step workflows proactively draw expert input on market from DeepSights before handing off to other agents to complete tasks. 

The connection also addresses the growing risk of business decisions being fed by incomplete or misleading information by generic AIs rather than specialized AI. DeepSights works the way an insights expert does to provide an accurate, evidence-backed view of the market. It analyzes information proactively, separating what is relevant from noise. DeepSights works only on trusted data and cites its references in every answer. 

“Your AI knows your company. DeepSights knows your market,” said Olaf Lenzmann, Chief Innovation and Product Officer at Market Logic. “Our customers have spent years and significant budgets building a unique understanding of their consumers and markets. Adding DeepSights at the market intelligence layer for enterprise AI ensures that competitive advantage is seized on and integral to decision making processes. The DeepSights MCP will make it easier than ever for trusted, evidence-backed market intelligence to flow freely through the organization.” 

Establishing DeepSights as the trusted market intelligence layer for all AI workflows also gives insights and IT teams one central way to govern and secure the knowledge that creates their unique market understanding. Insights team continues to decide which sources are trusted. User permissions in DeepSights controlling which sources an individual has access to are carried through by the MCP into information shared through other AI assistants. Because the connection is built on the open Model Context Protocol (MCP), the same governed layer serves every assistant and agent the company adopts. 

DeepSights MCP is generally available to DeepSights customers today. It works with Microsoft Copilot, ChatGPT, Claude, Glean and other assistants and agents that support the Model Context Protocol. For more information, visit www.marketlogicsoftware.com. 

About Market Logic Software 

Market Logic Software is a provider of pioneering market intelligence and insights solutions. Its AI-enabled platform, DeepSights, helps organizations make research and market intelligence available to decisionmakers across the enterprise at scale and speed. For more than 15 years, Market Logic has worked with consumer-focused brands around the world to support insights-driven decision-making. Customers include Vodafone, Bayer and Philips. More information is available at https://marketlogicsoftware.com. 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/market-logics-deepsights-mcp-scales-market-insights-reach-and-business-impact-through-enterprise-wide-ai-workflows-302899947.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

LONDON, Oct. 7, 2026 /PRNewswire/ — OncoBayes, a privately held clinical-stage pharmaceutical company, today announced the successful completion of preclinical work with OB-001, demonstrating the product’s potential to tackle two major unmet needs in oncology: ADC resistance and the brain penetration of tyrosine kinase inhibitors (TKIs). 

OB-001 is a highly selective and effective inhibitor of two key efflux pumps (P-gp and BCRP), which are present both on the blood-brain barrier and on tumour cells. The product is being developed as a once-daily oral tablet, which will be used in combination with a number of gold standard oncology treatments in order to optimise their efficacy. 

In perfused-brain mouse studies, OB-001 pretreatment significantly raised brain exposure of four gold standard kinase inhibitors – whilst systemic (plasma) exposure remained broadly unchanged. Data presented at AACR 2026 demonstrated that OB-001 could increase the brain exposure of osimertinib by almost 400% with minimal systemic changes[1],[2]. Based on a translational PK-PD-TGI model for osimertinib, this increase is projected to deliver a step-change in CNS progression-free survival for EGFRm NSCLC patients. The improved control of brain metastases is still a major area of unmet need in NSCLC and breast cancer. 

The same efflux pumps have also been identified as a key resistance mechanism impacting ADCs – with the over-expression of these pumps leading to reduced payload concentrations in the tumour. Preclinical work using a bidirectional transporter assay demonstrated that OB-001 reduces efflux for several leading payloads, including SN-38 (e.g. sacituzumab govitecan, Trodelvy®), DM4 (e.g. mirvetuximab soravtansine, Elahere®) and DXd (e.g. trastuzumab deruxtecan, Enhertu®). 

Plans are currently underway to move into a parallel clinical trial programme to generate POC data in combination with osimertinib, and also evaluate T-DXd re-sensitisation. 

“This is a critical milestone for our team, and we are now well positioned to initiate our clinical plans with OB-001” said Jim Millen, Chief Executive Officer for OncoBayes. “OB-001 is on track to become a first-in-class drug with broad potential as a simple, oral adjunct to a range of blockbuster oncology therapies. This is truly a pipeline in a product opportunity.” 

References: 1. AACR2026 Abstract 5873. 1 April 2026; 86 (7_Supplement): 5873. https://doi.org/10.1158/1538-7445.AM2026-5873.2. Cancer Research Communications 1 May 2026; 6 (5): 1213–1219. https://doi.org/10.1158/2767-9764.CRC-25-0553. 

View original content:https://www.prnewswire.co.uk/news-releases/oncobayes-progressing-ob-001-to-tackle-adc-resistance-and-tki-brain-penetration-302900100.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

Bitmine detiene il 4,9% dell’offerta complessiva di ETH, pari a 122,1 milioni di token 

In soli 15 mesi, Bitmine ha raggiunto il 99% dell’obiettivo «Alchemy of 5%» 

Tom Lee terrà il keynote alla conferenza Token2049 il 7 ottobre 2026 a Singapore 

Bitmine è stata inclusa nel Russell 1000 Large-cap Index il 26 giugno 2026 

Le azioni privilegiate di Serie A di Bitmine sono negoziate al NYSE con il simbolo BMNP 

Bitmine ha 5.067.309 ETH in staking, per un valore di 13,8 miliardi di dollari calcolato a 2.726 dollari per ETH. MAVAN (Made in America VAlidator Network) rappresenta una piattaforma di riferimento per lo staking di Ethereum destinata a BMNR e agli investitori istituzionali 

Bitmine detiene una partecipazione da 117 milioni di dollari in Eightco (NASDAQ: ORBS), una delle poche società quotate al mondo che offrono agli investitori un’esposizione indiretta a OpenAI 

Il valore complessivo delle disponibilità di Bitmine in criptovalute, liquidità, titoli negoziabili e investimenti «moonshot» ammonta a 17,4 miliardi di dollari e comprende 6,02 milioni di ETH, liquidità e titoli negoziabili per 643 milioni di dollari, oltre ad altre criptovalute 

Bitmine continua a essere sostenuta da un gruppo di investitori istituzionali di primo piano, tra cui Cathie Wood di ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital e l’investitore privato Thomas «Tom» Lee, a sostegno dell’obiettivo della società di acquisire il 5% dell’offerta di ETH 

NORWALK, Connecticut, 7 ottobre 2026 /PRNewswire/ — Bitmine Immersion Technologies, Inc. (NYSE: BMNR) («Bitmine» o la «Società»), società attiva nell’ecosistema Bitcoin ed Ethereum e focalizzata sull’accumulo di criptovalute come investimento di lungo termine, ha annunciato oggi che il valore complessivo delle proprie disponibilità in criptovalute, liquidità, titoli negoziabili e investimenti «moonshot» ammonta a 17,4 miliardi di dollari. 

Alle 18:30 ET del 4 ottobre 2026, le partecipazioni in criptovalute della Società comprendono 6.016.414 ETH al prezzo di 2.726 per ETH (fonte Coinbase NASDAQ: COIN), 214 Bitcoin (BTC), una partecipazione da 180 milioni di dollari in Beast Industries, una partecipazione da 117 milioni di dollari in Eightco Holdings (NASDAQ: ORBS), classificata tra gli investimenti «moonshot», e liquidità e titoli negoziabili per un totale di 643 milioni di dollari. Le partecipazioni in ETH di Bitmine rappresentano il 4,9% dell’offerta complessiva di Ethereum, pari a 122,1 milioni di ETH. 

«Crediamo che mentre le criptovalute entrano in un ciclo che consideriamo un mercato rialzista, ciò che è degno di nota è la sovraperformance del prezzo azionario di Bitmine rispetto all’ETH durante il mercato ribassista del 2025-2026. Nei primi 9 mesi del 2026, ETH è diminuito del 10%, mentre BMNR è scesa del 3%, equivalente a una sovraperformance di 731 punti base», ha dichiarato Thomas «Tom» Lee, presidente di Bitmine. 

«A nostro avviso, la performance dell’azione BMNR riflette l’impegno della Società ad ottimizzare il rendimento degli azionisti. E questo è stato da noi realizzato attraverso molti interventi, tra cui l’esecuzione del più grande riacquisto di sempre di azioni con tesoreria in criptovalute, acquistando 21 milioni di azioni solo nel 2026», ha proseguito Lee. 

«La sovraperformance di ETH di 6.832 punti base rispetto all’S&P 500 nel 3T26 è degna di nota se si considerano i sostanziali venti contrari macroeconomici che sono emersi nel trimestre, tra cui una Fed “aggressiva”, l’aumento del petrolio, l’incremento dei rendimenti obbligazionari globali e il generale inasprimento delle condizioni finanziarie. Da inizio trimestre, ETH ha registrato una sovraperformance di 6.832 punti base, distanziando altri asset macro», ha dichiarato Lee. 

Tom Lee terrà inoltre il keynote alla conferenza Token2049 il 7 ottobre alle 10:00 presso il Marina Bay Sands a Singapore. Il keynote di 20 minuti fa parte di Token2049, la più grande conferenza al mondo dedicata alle criptovalute. Ulteriori informazioni sono disponibili sul sito web della conferenza Token2049. 

«Nell’ultima settimana abbiamo acquistato 15.112 ETH. Nessuna società quotata al mondo può vantare una continuità negli acquisti di criptovalute paragonabile a quella di Bitmine. Bitmine ha acquistato ETH ogni settimana dall’avvio della propria ETH Treasury Strategy, il 30 giugno 2025», ha dichiarato Lee. 

Bitmine rilascerà il più recente Messaggio del Presidente per il mese di ottobre 2026 questa settimana. Il titolo del Messaggio è «Il ciclo rialzista delle criptovalute è in corso e potrebbe trattarsi del più significativo mai osservato». 

All’inizio del 2026, Bitmine ha lanciato MAVAN, acronimo di Made in America VAlidator Network, la propria piattaforma di staking di livello istituzionale. Inizialmente sviluppata per supportare la tesoreria in Ethereum di Bitmine, MAVAN è stata successivamente ampliata per servire investitori istituzionali, società di custodia e partner dell’ecosistema alla ricerca di un’infrastruttura di staking di livello professionale. Una parte degli ETH detenuti da Bitmine è già in staking sulla piattaforma MAVAN. 

Al 4 ottobre 2026, Bitmine aveva complessivamente 5.067.309 ETH in staking, per un valore pari a 13,8 miliardi di dollari, calcolato a 2.726 dollari per ETH. «Bitmine ha messo in staking più ETH di qualsiasi altra entità al mondo. A regime, quando tutti gli ETH di Bitmine saranno messi in staking tramite MAVAN e i suoi partner, le ricompense da staking previste ammonteranno a 431 milioni di dollari su base annualizzata, sulla base di un rendimento BMNR a 7 giorni del 2,63%», ha dichiarato Lee. 

«I ricavi annualizzati derivanti dallo staking sono attualmente stimati in 363 milioni di dollari. I 5,1 milioni di ETH in staking rappresentano l’84% dei 6,02 milioni di ETH detenuti da Bitmine. Le attività di staking gestite direttamente da Bitmine hanno generato un rendimento a 7 giorni pari al 2,63% su base annualizzata», ha proseguito Lee. 

Bitmine è uno dei titoli più scambiati negli Stati Uniti. Secondo i dati di Fundstrat, il titolo ha registrato un volume medio giornaliero di scambi pari a 827 milioni di dollari (media a 5 giorni, al 2 ottobre 2026), classificandosi al 125° posto negli Stati Uniti, dietro a Bristol-Myers Squibb Co (124° posto) e davanti a Schlumberger NV (126° posto) tra i 5.704 titoli quotati negli Stati Uniti (statista.com e ricerca di Fundstrat). 

Le disponibilità di criptovalute di Bitmine la collocano al primo posto tra le società con una tesoreria in Ethereum al mondo e al secondo posto tra le tesorerie crypto a livello globale, dietro a Strategy Inc. (NASDAQ: MSTR), che secondo quanto riportato detiene 847.666 BTC per un valore di circa 78 miliardi di dollari. Bitmine rimane la maggiore società al mondo per consistenza della tesoreria in Ethereum.  

Il management di Bitmine ritiene che il GENIUS Act e il Project Crypto della Securities and Exchange Commission (SEC) possano avere sui servizi finanziari nel 2026 un impatto trasformativo paragonabile a quello dell’intervento statunitense del 15 agosto 1971, che pose fine al sistema di Bretton Woods e sganciò il dollaro statunitense dalla convertibilità in oro 55 anni fa. L’evento del 1971 rappresentò il catalizzatore della modernizzazione di Wall Street, contribuendo alla nascita dei grandi protagonisti della finanza e delle infrastrutture finanziarie e di pagamento che conosciamo oggi. Questi si sono poi rivelati investimenti più redditizi dell’oro. 

Il messaggio del Presidente è disponibile qui: 

https://www.Bitminetech.io/chairmans-message
 

La presentazione dei risultati dell’intero esercizio fiscale 2025 e la presentazione societaria sono disponibili qui: https://Bitminetech.io/investor-relations/  

Per ricevere aggiornamenti, è possibile registrarsi qui: https://Bitminetech.io/contact-us/  

Informazioni su Bitmine 

Bitmine Immersion Technologies, Inc. (NYSE: BMNR), insieme alle proprie controllate («Bitmine» o la «Società»), è un’azienda attiva nelle infrastrutture tecnologiche blockchain e opera nei servizi istituzionali di staking e validazione di asset digitali, nel mining di Bitcoin e nella gestione strategica di asset digitali. In qualità di principale società al mondo con una tesoreria in Ethereum, adotta una strategia innovativa di gestione degli asset digitali destinata agli investitori istituzionali e agli investitori nei mercati regolamentati. La Società fornisce infrastrutture di staking e validazione di livello istituzionale, attraverso le quali genera ricompense da staking e ricavi derivanti dalla validazione, oltre a svolgere attività di mining di Bitcoin. Bitmine detiene strategicamente asset digitali e genera rendimenti su tali disponibilità a sostegno della liquidità e della raccolta di capitale. Dal 2025, la Società ha ampliato le proprie capacità infrastrutturali nel settore blockchain, includendo lo sviluppo e l’implementazione di MAVAN, la propria piattaforma istituzionale di staking e validazione. Le attività della Società comprendono inoltre investimenti in opportunità blockchain in fase iniziale, ad alto potenziale, nonché servizi accessori di mining, gestione di infrastrutture e consulenza. 

Per altre informazioni, segui Bitmine su X: 

https://x.com/bitmnr
 

https://x.com/fundstrat
 

Avvertenza sulle dichiarazioni previsionali 

Il presente comunicato stampa contiene dichiarazioni che costituiscono «dichiarazioni previsionali» ai sensi del Private Securities Litigation Reform Act del 1995, e successive modifiche. Le dichiarazioni previsionali comprendono tutte le dichiarazioni che non hanno natura esclusivamente storica e possono generalmente essere identificate dall’uso di termini quali «si attende», «proietta», «intende», «pianifica», «crede», «si aspetta», «stima», «può», «potrà», «potrebbe», «dovrebbe», «ritiene» o espressioni analoghe. In particolare, il presente comunicato stampa contiene dichiarazioni previsionali riguardanti: (i) l’obiettivo della società di acquisire il 5% dell’offerta complessiva di ETH, nell’ambito dell’iniziativa «Alchemy of 5%»; (ii) la strategia della Società relativa all’accumulo e alla gestione di asset digitali in tesoreria, incluse le dichiarazioni riguardanti gli acquisti settimanali continuativi di ETH e il posizionamento della Società come maggiore tesoreria in ETH al mondo; (iii) le attività di staking della Società, incluse le ricompense annualizzate di staking di ETH stimate in circa 431 milioni di dollari a regime e i ricavi annualizzati da staking attualmente stimati in circa 363 milioni di dollari; (iv) l’espansione di MAVAN per servire investitori istituzionali, società di custodia e partner dell’ecosistema; (v) le convinzioni del management in merito alle condizioni del mercato delle criptovalute e alla sovraperformance del prezzo azionario rispetto a ETH; (vi) la performance relativa di ETH rispetto all’indice S&P 500 e ad altri asset macro; (vii) la convinzione del management secondo cui il GENIUS Act e il Project Crypto della SEC potrebbero avere un impatto trasformativo sui servizi finanziari; e (viii) le dichiarazioni relative al valore delle disponibilità della Società in criptovalute, liquidità, titoli negoziabili e investimenti «moonshot». 

Tali dichiarazioni previsionali comportano rischi e incertezze significativi che potrebbero determinare risultati effettivi sostanzialmente diversi da quelli espressi o implicitamente indicati. Tra i fattori che potrebbero determinare o contribuire a tali differenze figurano, a titolo esemplificativo e non esaustivo: l’estrema volatilità e imprevedibilità dei prezzi degli asset digitali, inclusi ETH e Bitcoin; la dipendenza della Società da fonti terze per la determinazione dei prezzi e dai valori di mercato riportati, che possono fluttuare in modo significativo; le variazioni delle condizioni di mercato che influenzano il prezzo e i volumi di negoziazione dei titoli della Società; la capacità della Società di attuare con successo la propria strategia di acquisizione di asset digitali e raggiungere i propri obiettivi di accumulo di ETH, compreso l’obiettivo «Alchemy of 5%», la capacità della Società di finanziare le proprie attività operative e l’espansione di MAVAN; i rischi operativi, di sicurezza e tecnologici connessi alle attività di staking e validazione della Società, inclusi i guasti di rete, eventi di slashing, violazioni della cybersicurezza e modifiche ai protocolli; il rischio che i rendimenti, le ricompense e i ricavi effettivi dello staking differiscano in misura significativa dagli importi previsionali; la concorrenza nel settore della tesoreria di asset digitali, dello staking e del mining; la dipendenza della Società da figure chiave; gli sviluppi normativi riguardanti gli asset digitali, la tecnologia blockchain e le attività di staking, compresa l’eventuale approvazione definitiva, attuazione e interpretazione del GENIUS Act e di altre proposte legislative; le iniziative della SEC, della CFTC e di altri organismi di regolamentazione; i rischi connessi agli investimenti «moonshot» della Società, inclusi quelli in Eightco Holdings e Beast Industries; i fattori macroeconomici, tra cui inflazione, tassi di interesse e condizioni economiche generali; eventuali modifiche al protocollo Ethereum; la performance dei fornitori terzi di servizi, degli exchange, delle società di custodia e dei partner di staking; nonché gli altri fattori di rischio descritti nei documenti presentati dalla Società presso la SEC. 

Le dichiarazioni previsionali contenute nel presente comunicato stampa si basano sulle informazioni a disposizione del management alla data del presente comunicato e riflettono le attuali aspettative, stime e convinzioni del management in merito a eventi futuri. I risultati effettivi potrebbero differire in misura significativa da quelli espressi o impliciti per effetto dei fattori sopra descritti e di quelli riportati nella sezione «Risk Factors» dell’Annual Report della Società su Form 10-K relativo all’esercizio chiuso al 30 settembre 2025, depositato presso la SEC il 21 novembre 2025, nei Quarterly Reports della Società su Form 10-Q e negli altri documenti depositati dalla Società presso la SEC, come eventualmente modificati o aggiornati nel tempo. Copie di tali documenti sono disponibili su www.sec.gov e su https://Bitminetech.io/investor-relations/. La Società invita i lettori a non fare eccessivo affidamento sulle dichiarazioni previsionali, che riflettono esclusivamente le circostanze esistenti alla data in cui vengono formulate. Bitmine declina espressamente qualsiasi obbligo di aggiornare o rivedere dichiarazioni previsionali, salvo quanto previsto dalla legge applicabile. 

View original content to download multimedia:https://www.prnewswire.com/it/comunicati-stampa/bitmine-immersion-technologies-bmnr-annuncia-che-le-partecipazioni-in-eth-hanno-raggiunto-6-02-milioni-di-token-e-che-il-valore-complessivo-delle-disponibilita-in-criptovalute-liquidita-e-titoli-negoziabili-ammonta-a-17-4-milia-302900602.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

WASHINGTON, Oct. 7, 2026 /PRNewswire/ — The Sultan of Afar Ahmed Alimirah is calling for support for the United Nations and African Union’s call for de-escalation and talks to promote peace in the Ethiopian homeland of the Afar. A statement entitled “This is Not Our War” details the plight of the Afar people, one of the most disadvantaged and economically neglected ethnic groups in Ethiopia. It calls for an end to conflict in the area. 

“Afars have repeatedly paid the price for wars we did not start,” the statement said. “Today, as fighting once again enters the Afar Region, our people face yet another catastrophe: homes abandoned, livestock lost, lives cut short, and another generation scarred by war.” 

As the war wages around them, the Afar have suffered displacement, restricted access to emergency assistance, and severed communication. Last year, 11 Afar in Siyaru, a remote village near the Ethiopia-Djibouti border, were killed by a Djiboutian drone strike which they claim targeted rebel terrorists from the Front for the Restoration of Unity and Democracy (Frud). Investigations revealed that the strike hit just over the Ethiopian border in civilian territory, killing women, children, and the elderly in a community already struggling to survive. Ahmed Alimirah, was the only voice condemning the strikes.
 

Now, the Afar occupy land in the Addis Ababa to Djibouti corridor, which moves more than 95 percent of the country’s trade by volume. The region’s importance has now turned the Afar homeland into a proxy battlefield. 

The Sultanate will initiate talks with the United Nations and African Union to de-escalate the conflict through dialogue. 

 “The Afars have defended their homeland throughout history and sacrificed in defense of Ethiopia long before today’s governments, political parties, and armed movements existed,” the statement says. “This war must be resolved through dialogue. We support the United Nations’ and the African Union’s call for immediate de-escalation and talks. The path of peace through genuine dialogue and respect for Ethiopia’s sovereignty must be pursued.” 

To read the statement, “This is Not Our War,” click here. For more information on the humanitarian crisis in the Afar region, contact office@afarsultanate.org
 

MEDIA CONTACT: 

Abdullah Alimirah 

office@afarsultanate.org
 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/sultan-of-afar-calls-for-de-escalation-of-conflict-in-afar-homeland-302900583.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

ALTSTÄTTEN, Switzerland and BOSTON, Oct. 6, 2026 /PRNewswire/ — icotec, the global leader in radiolucent implants for spine tumors and other complex spinal surgery patients, today announced that the Centers for Medicare & Medicaid Services (CMS) has approved a New Technology Add-On Payment (NTAP) for icotec’s spine implant system, CMORE® CT, effective October 1, 2026. 

This approval represents an important milestone for icotec and its CMORE® CT System. The NTAP program can help eligible hospitals receive reimbursement for treating Medicare patients with the innovative CMORE® product. The CMS designation provides an additional payment to eligible hospitals for qualifying technologies used for traditional Medicare patients. The CMORE® NTAP applies to specified spinal conditions and procedures. 

“We are thrilled that CMS has recognized our new CMORE® CT System through the NTAP program, after previously receiving the Break-Through Device Designation (BDD) in April, 2025,” said Christoph Eigenmann, CEO of icotec, USA. “Through this new acknowledgement, clinicians have an approved solution to provide their patients the CMORE® CT System. This empowers the ability to SEE MORE during surgery in XRAY, CT and MRI imaging and enables advanced therapies postoperatively thanks to the radiolucent properties of BlackArmor® Carbon/PEEK.” 

With its BlackArmor® Carbon/PEEK implants, icotec combines its proprietary process technologies with advanced material science to deliver innovative and reliable solutions for spine surgeons and their patients around the world. icotec works with clinicians in a multi-disciplinary therapy approach to advance the field of spinal implants and shape the future of spinal surgery. 

For additional inquiries, please contact hello@icotec-medical.com. 

About icotec’s CMORE® CT System 

The CMORE® CT System is designed for posterior stabilization of the cervicothoracic spine and is engineered and manufactured with icotec’s proprietary BlackArmor® technology. The nonmetallic, radiolucent system is made entirely of Carbon/PEEK and includes polyaxial screws (pedicle and lateral mass) as well as straight and precontoured rods to accommodate patient anatomy. The CMORE® CT system is indicated to treat most of today’s posterior cervicothoracic spinal pathologies and is the only posterior cervicothoracic system approved by the FDA for the treatment of spinal infection. 

The above information is provided by icotec regarding the NTAP program, is for communication purposes only and does not constitute billing or coding advice. Eligibility and reimbursement are determined by CMS and applicable payer requirements. icotec does not guarantee any specific reimbursement. 

For additional information about icotec and the CMORE® product, please visit www.icotec-medical.com. Healthcare professionals and hospital representatives seeking more information about the CMORE® CT System NTAP program, please contact reimbursement@icotec-medical.com. 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/icotec-receives-cms-approval-for-new-technology-add-on-payment-for-its-cmore-ct-system-302900166.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

CAMBRIDGE, England, Oct. 6, 2026 /PRNewswire/ — Cambridge Heartwear® Limited (www.camheartwear.com) has secured a landmark £184 million tender with the National Health Service (NHS) of the UK for HeartSense®, the world’s first medical-grade, multi-channel, portable, wirelessly charged ECG wearable straight to one’s mobile phone, representing a significant advancement in global Medical technology, AI application and cardiovascular diagnostics.  

The agreement with the UK National Health Service Supply chain enables the deployment of advanced cardiac monitoring technology across primary and secondary care and civil service departments, empowering patients to diagnose heart rhythm problems whenever and wherever they are to prevent heart failure and strokes earlier, reduce waiting times and support a more preventative approach to Heart Disease, which can take place in the comfort of their own homes.  

HeartSense® is the world’s first wearable to combine diagnostic-grade multi-channel ECG monitoring, adaptive artificial intelligence and wireless charging in a single device. Manufactured to bridge the gap in women’s cardiovascular care with its ergonomic design, the technology gives healthcare professionals and patients access to continuous, real-time ECG data on a mobile phone. giving you back the control of your health at every stage.  

Engineered in Cambridge and manufactured in Britain, HeartSense® has been developed to help identify cardiovascular disease and stroke risk before conditions become acute. Its proprietary engineering and AI technology with (86 patents ) support earlier intervention, enabling clinicians to make more informed decisions and improve patient outcomes.  

The system is UKCA approved and ISO 13845 certified, with FDA 510(k) applications currently in progress.  

“We did not have a UK ECG manufacturer and reporter until now,” said Professor Rameen Shakur, Founder of Cambridge Heartwear. “HeartSense® is the world’s first medical-grade, AI-powered, multi-channel ECG wearable and demonstrates what can be achieved when clinicians, engineers and AI specialists work together. We want to help move healthcare towards earlier diagnosis, better prevention and improved outcomes for patients across the NHS.”  

The partnership with the NHS Supply Chain allows Integrated Care Boards to deploy HeartSense® at scale, supporting the delivery of diagnostic-quality heart monitoring beyond hospital environments. The initiative is intended to reduce pressure on secondary care services while improving access to high-quality cardiac diagnostics in community settings.  

Founded by Professor Rameen Shakur, Cambridge Heartwear is a medical technology company based at Cambridge Science Park coming out of the University of Cambridge dedicated to making heart health monitoring simple, accessible and accurate. Combining medical research, engineering excellence and artificial intelligence, the company develops advanced wearable technologies that empower patients and healthcare professionals with diagnostic-quality cardiovascular insights anytime, anywhere. HeartSense® helps detect heart conditions earlier, enabling more informed clinical decision-making and better patient care. 

Contact: info@camheartwear.com
 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/cambridge-heartwear-awarded-184-million-nhs-tender-for-worlds-first-medical-grade-wirelessly-charged-reusable-ecg-wearable-302900084.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

Live case showcases successful below-the-knee revascularization with two MOTIV® scaffolds; late-breaking analysis shows higher efficacy endpoint rates with MOTIV versus balloon angioplasty in both Rutherford 4 and Rutherford 5 CLTI populations 

SAN DIEGO, Oct. 6, 2026 /PRNewswire/ — REVA Medical, LLC today announced the successful completion of a live case demonstration featuring the MOTIV® sirolimus-eluting bioresorbable vascular scaffold and the presentation of late-breaking clinical results from the MOTIV BTK pivotal trial at the Vascular InterVentional Advances (VIVA) 2026 conference in Las Vegas, Nevada. 

Live Case Demonstration 

Professor Andrej Schmidt, MD, of University Hospital Leipzig, performed a live, below-the-knee revascularization procedure transmitted to attendees at VIVA26 in Las Vegas. The patient, a 72-year-old woman with peripheral vascular chronic limb-threatening ischemia (CLTI), was classified as Rutherford Category 5 and presented with a nonhealing ulcer. 

Prof. Schmidt successfully treated the patient using two MOTIV sirolimus-eluting bioresorbable scaffolds: a 4.0 mm × 48 mm MOTIV scaffold and a 3.5 mm × 24 mm MOTIV scaffold. The procedure achieved successful revascularization of the below-the-knee peripheral artery with an excellent angiographic result. 

Late-Breaking Clinical Trial Presentation 

Ehrin Armstrong, MD, of HCA HealthOne Swedish Medical Center in Denver, Colorado, presented a subgroup analysis from the MOTIV pivotal trial during VIVA26’s Late-Breaking Clinical Trials session. The presentation, titled “Clinical Outcomes of the MOTIV Sirolimus-Eluting Resorbable Scaffold in Rutherford Category 4 Versus Rutherford Category 5 Chronic Limb-Threatening Ischemia: Subgroup Analysis From the MOTIV Pivotal Trial,” evaluated outcomes in patients with two severities of CLTI. 

The prospective, multicenter, single-blind randomized controlled trial enrolled 292 patients with Rutherford Category 4 or 5 CLTI and compared the MOTIV scaffold with standard balloon angioplasty (PTA). The study population was highly complex: 69% of enrolled patients were Rutherford 5. 

In the subgroup analysis, the composite endpoint of limb salvage and primary patency favored MOTIV over PTA at both 6 and 12 months in each Rutherford category: 

“Today’s live case demonstration and the late-breaking MOTIV results brought the potential of our bioresorbable scaffold technology into sharp focus at VIVA26,” said Jeffrey Anderson, President and Chief Executive Officer of REVA Medical. “The successful procedure and the consistent clinical outcomes observed across both Rutherford 4 and Rutherford 5 patient populations reinforce our commitment to addressing the needs of patients with complex below-the-knee disease.” 

CLTI is the most severe form of peripheral artery disease and may lead to severe pain, non-healing wounds, and amputation. The MOTIV bioresorbable scaffold is designed to open blocked arteries, support the vessel during healing, and then gradually be reabsorbed by the body without leaving a permanent implant. 

CAUTION: Investigational device. Limited by Federal (U.S.) law to investigational use only. 

About REVA Medical 

REVA Medical is a medical device company focused on developing and commercializing bioresorbable polymer technologies for vascular applications. The company’s proprietary Tyrocore® polymer platform combines strength, radiopacity, and controlled degradation, enabling innovative solutions such as the MOTIV® bioresorbable scaffold for peripheral artery disease. Visit us on social media: LinkedIn
 

View original content to download multimedia:https://www.prnewswire.com/news-releases/reva-medical-announces-successful-motiv-live-case-demonstration-and-late-breaking-btk-trial-results-at-viva26-302900059.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

Capecchi: “Evitiamo strumentalizzazioni”

Le parole del Sindaco: “Siamo di fronte a temi e ad argomenti estremamente delicati, rispetto ai quali l’aula e la politica tutta dovrebbero dimostrare la massima misura e evitare strumentalizzazioni.

Desidero esprimere la mia vicinanza e la mia più sincera solidarietà a chi ha vissuto la sofferenza per la perdita di una figlia o di un figlio. Allo stesso tempo, ritengo doveroso garantire rispetto, vicinanza e tutela a tutte le donne che hanno affrontano la scelta di interrompere una gravidanza.

Pur non condividendo il tono, le parole pronunciate in aula dalla consigliera Ferrari si inseriscono nel contesto della difesa dei diritti civili e delle libertà individuali. Penso che la nostra comunità debba saper coniugare il rispetto per il dolore privato e la tutela delle decisioni personali delle donne

Elisa Montemagni segretaria provinciale Lega Salvini Lucca.

La deputata toscana, già consigliera regionale, è stata eletta nel congresso provinciale che si è tenuto a Lucca presieduto dalla deputata Tiziana Nizini.

Presenti il deputato Andrea Crippa, commissario regionale Lega Toscana, e Mario Pardini, sindaco di Lucca, pronto per la candidatura per un mandato bis alle amministrative 2027.

Pardini che, come sottolinea via social Tiziana Nisini, “con la sua presenza ha dimostrato vicinanza e sostegno”.

Elisa Montemagni riceve il testimone dal commissario Andrea Cella, vicesindaco del Comune di Massa guidato dal sindaco Francesco Persiani.

Eletto anche il nuovo direttivo provinciale, composto da Ilaria Benigni, Salvadore Bartolomei, Mauro Santini, Antonio Tognini, Samuel Venturi e Donatella Ciuffolini.

La neo segretaria provinciale Elisa Montemagni: “Il congresso rappresenta sempre un bel momento di democrazia interna. Sono molto onorata di poter dare il mio fattivo contributo, per ripartire insieme più forti anche in vista delle rilevanti sfide elettorali del 2027. In provincia, oltre al capoluogo, andranno al voto pure Comuni molto importanti, dove, come Lega, siamo pronti a dare il nostro contributo, grazie ad una classe dirigente solida e costituita da persone preparate.

Mi metterò immediatamente al lavoro e mi confronterò, dunque, quanto prima, con i militanti e sostenitori della nostra splendida provincia lucchese. Il contatto con il territorio e quindi con i cittadini rimarrà l’elemento fondamentale della nostra attività, visto che tale approccio è, da sempre, nel dna della Lega.

Grazie ai militanti per avermi scelta alla guida di questo meraviglioso gruppo fatto di persone preparate e di una classe dirigente solida e coesa.

CINZIA GORLA

Emmaneel joins Brand Activations & Events (BAE) to scale complex global event portfolios while keeping each experience creatively distinct and commercially accountable. 

LAS VEGAS, Oct. 6, 2026 /PRNewswire/ — Spiro®, a global experiential agency, today announced the appointment of John Emmaneel as Executive Vice President, Global Operations & Innovation for its Brand Activations & Events (BAE) division. 

Emmaneel will lead how BAE plans, staffs and delivers work across markets, while building new capabilities as client needs change. He will work alongside Jen Shankman, Executive Vice President, BAE Growth, who leads the division’s growth and strategic relationships. Both report to Carley Faircloth-Kilmurray, Global Chief Marketing, Strategy & Brand Experiences Officer. 

“BAE combines the structure to manage a global portfolio with the creative pulse to make every experience distinct. John understands how to make that real at scale,” said Faircloth-Kilmurray. “He has spent more than 25 years building teams and capabilities around complex client needs. He knows how to turn ambitious ideas into work that performs, with the operational depth to deliver it around the world.” 

Emmaneel joins Spiro from Invision, where he led the agency’s innovation practice and Chicago office, spearheaded the Gaming & Entertainment practice while expanding services and regional growth. His career also includes leadership roles at Kenwood Experiences and Jack Morton Worldwide, with work for brands including Square Enix, Google, Intel, NVIDIA, Samsung, and Northwestern Mutual. 

“What drew me to Spiro was the mix inside BAE: serious strategic and operational depth paired with the appetite to create work people genuinely care about,” said Emmaneel. “There is a strong foundation here and real ambition for what comes next. I’m looking forward to connecting more of the agency’s expertise across markets and helping teams deliver ambitious work for clients.” 

About Spiro Brand Activations & Events  

We are event operators by craft and growth strategists by orientation, connecting every decision to the business behavior it is meant to create. The result is live work that feels alive and changes what happens next. 

Spiro Brand Activations & Events is Spiro’s specialist team for conferences, product launches, corporate meetings, festivals and brand activations. Built from enterprise event and consumer experiential expertise, BAE brings structure to the whole portfolio and a creative pulse to every experience.  

That is how BAE delivers the promise of Experience Brand Gravity™, bonding brand and customer. 

About Spiro 

Spiro (sp-eye-roh) is a strategically led, creatively driven global experiential agency setting the benchmark for how brands connect and grow. By accelerating Brand Gravity™, the data-informed, emotional and behavioural pull between brands and their audiences, Spiro makes brands experiential. Globally connected and trusted by some of the world’s most influential brands, Spiro creates the pull that keeps customers coming back. Learn more at spiro.com. 

Media ContactMelissa BurnsSenior Director of Marketingmburns@thisisspiro.com
 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/spiro-names-john-emmaneel-to-lead-global-operations-and-innovation-for-brand-activations–events-division-302898728.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

RANCHO CUCAMONGA, Calif., Oct. 6, 2026 /PRNewswire/ — New World Medical is pleased to announce the Ahmed® Glaucoma Valve (AGV), Ahmed ClearPath® (ACP), and KDB GLIDE® have received Medical Device Regulation (MDR) certification in the European Union. These products have been commercially available in Europe under the previous Medical Device Directive (MDD) framework, and MDR certification represents a successful transition to the European Union’s updated regulatory requirements. 

This important milestone reflects the company’s ongoing commitment to advancing glaucoma care and expanding access to vision-preserving treatment options for surgeons and patients globally. 

“We are proud to reach this important milestone for New World Medical,” said Raymond Kong, Chief Commercial Officer. “MDR certification reflects the tremendous effort and collaboration across our organization and enables us to continue supporting glaucoma surgeons in Europe with innovative solutions for their patients.” 

Looking ahead, New World Medical is working toward adding additional products in its portfolio to the MDR certification with priority on the Ahmed ClearPath® ST (ACP ST), which is currently approved in over 20 countries globally and has become a trusted treatment option for surgeons managing refractory glaucoma. 

“European surgeons have expressed growing interest in the ACP ST, a next-generation small-tube glaucoma drainage device designed to provide additional surgical flexibility,” said Raymond Kong. The MDR certification of ACP represents an important step forward in New World Medical’s European growth strategy and establishes a strong regulatory foundation for future expansion of the Ahmed ClearPath portfolio, including ACP ST. The company is actively working with its notified body to obtain MDR certification for ACP ST and bring this innovative technology to surgeons across Europe. 

This achievement further strengthens New World Medical’s global glaucoma portfolio and supports the company’s mission to preserve and enhance vision and benefit humanity through innovative solutions for patients worldwide. 

About New World Medical  

New World Medical was founded by Dr. A. Mateen Ahmed, with a mission to benefit humanity. New World Medical pursues this purpose by developing and manufacturing innovative surgical devices that provide vision-preserving treatments for patients with glaucoma. 

New World Medical’s product portfolio includes its flagship devices: the market-leading glaucoma drainage device – the Ahmed® Glaucoma Valve; the Ahmed ClearPath®; the KDB GLIDE®; the STREAMLINE® Surgical System; and the VIA360™ Surgical System. 

To learn more about New World Medical, visit https://www.newworldmedical.com. 

Media Contact:  

Raymond Kong Chief Commercial Officer rkong@newworldmedical.com
 

View original content to download multimedia:https://www.prnewswire.com/news-releases/new-world-medical-receives-mdr-certification-for-ahmed-glaucoma-valve-ahmed-clearpath-and-kdb-glide-302899021.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

Eye-tracked 60GHz streaming over the first 2×2 MIMO wireless link on a VR headset; Pimax also debuts Ringless VR Controllers, the Spation mini-PC, and a new Stratosphere Blue brand identity 

SAN JOSE, Calif., Oct. 6, 2026 /PRNewswire/ — Pimax, a leading manufacturer of high-end PC virtual reality headsets, today unveiled Crystal Pro, a wireless PC VR headset built around a streaming technology it calls Native Foveated Streaming, at its “Frontier: Change To Stay The Same” launch event. Pimax also debuted Ringless VR Controllers, the Spation mini-PC, and a refreshed brand identity built around a new signature color, Stratosphere Blue. 

Crystal Pro ships with built-in Wi-Fi streaming and a dedicated Wi-Fi 6E adapter. For the GPU’s native image, Pimax offers an optional 60G AirLink kit, bundled or sold separately. Using eye-tracking, its 60GHz connection sends the GPU’s native image directly to the panels in the user’s focus area, without the encoding Wi-Fi streaming requires. The kit’s two Room Antennas run in a 2×2 MIMO configuration — a first for VR headsets, Pimax says — for up to 6 Gbps combined throughput and under 2ms of added latency. 

The headset pairs aspheric glass lenses with QLED panels at 2880 x 2880 pixels per eye, a 110-degree field of view, and refresh rates up to 120Hz. Tracking combines eye-tracking, SLAM 2.0 inside-out tracking, and a swappable faceplate for optional Lighthouse support or MR passthrough with LiDAR depth. No battery is built in; power comes from an included 16,000mAh external pack. 

Ringless VR Controllers replace Pimax’s earlier tracking ring with camera-based hand tracking plus infrared and motion-sensor tracking, under 15ms latency, and clip into a gamepad for Windows and Steam. 

Spation is a mini-PC with desktop-class components in a chassis smaller than a typical tower, pairing an AMD Ryzen 7 9800X3D CPU with an AMD RX 9070 XT or Nvidia RTX 5070 Ti GPU. It supports Windows and SteamOS, with a DIY configuration also available. 

Crystal Pro is priced at $1,399, or $1,899 bundled with the AirLink kit; the kit alone is $599. Shipping dates, and pricing for Ringless VR Controllers and Spation, will follow. Customers can reserve one for $1 today at pimax.com. 

Pimax is a virtual reality hardware company known for high-resolution, wide-field-of-view PC VR headsets, including the Crystal and Dream Air series. More at www.pimax.com. 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/pimax-unveils-crystal-pro-with-native-foveated-streaming-sending-the-gpus-native-image-wirelessly-to-the-headset-302899622.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

La Toscana avvia la macchina della prevenzione autunnale contro l’influenza e il Covid-19. La campagna vaccinale regionale si muoverà a scaglioni seguendo precise tempistiche, dando la priorità alle fasce di popolazione più esposte per ragioni anagrafiche, di salute o professionali.

La profilassi antinfluenzale prenderà il via mercoledì 7 ottobre, concentrandosi inizialmente sugli ospiti delle Rsa, grazie all’intervento dei medici di famiglia affiancati dal personale delle aziende sanitarie. Una settimana dopo, a partire dal 14 ottobre, la copertura sarà estesa ai bambini di età compresa tra i sei mesi e i sei anni e alla fascia di popolazione dai sessant’anni in su.

Per le restanti categorie individuate dal Ministero della Salute l’accesso gratuito si aprirà l’11 novembre. Da questa data potranno ricevere il vaccino i malati cronici e i soggetti fragili a prescindere dall’età, le donne in gravidanza, il personale sanitario e sociosanitario (inclusi i tirocinanti), gli addetti ai servizi essenziali, i donatori di sangue, chi lavora a stretto contatto con gli animali, oltre ai familiari e ai conviventi di persone ad alto rischio.

Sul fronte del Covid-19, la campagna partirà il 14 ottobre, seguendo le priorità della circolare ministeriale e iniziando dalle Rsa e dai soggetti vulnerabili. Nella stessa giornata verranno aperte le prenotazioni sul portale web della Regione, mentre dal 21 ottobre le somministrazioni saranno effettuate anche all’interno dei centri vaccinali delle Asl. Il siero fornito dal Ministero, in distribuzione dalla fine di settembre, è basato sulla tecnologia a mRna ed è stato aggiornato per contrastare la variante Xfg. In una fase successiva, qualora le scorte di magazzino lo consentano, la vaccinazione anti-Covid potrebbe essere aperta anche alla popolazione non rientrante nelle categorie raccomandate.

Dal punto di vista operativo, i cittadini potranno ricevere entrambe le iniezioni contemporaneamente, a patto che non vi siano controindicazioni mediche specifiche. La somministrazione capillare sul territorio è affidata ai medici di medicina generale e ai pediatri di libera scelta. Esclusivamente per la platea degli over 60, è prevista la possibilità di rivolgersi anche alle farmacie convenzionate aderenti all’iniziativa.

L’obiettivo del piano è stato inquadrato dal presidente della Regione Eugenio Giani e dall’assessora alla sanità Monia Monni. “Vaccinarsi ora è un modo per garantire una protezione tempestiva in vista della stagione autunnale e invernale”, hanno spiegato i due rappresentanti istituzionali, ricordando come i preparati agiscano limitando le forme più gravi della malattia. Una tutela rivolta ai singoli e ai fragili che, riducendo i ricoveri, si traduce in “un vantaggio per la salute delle persone, ma con un impatto positivo anche sulla sostenibilità del servizio sanitario regionale”.

REDAZIONE